SEC Tracker
Get the app

Stem STEM

Stem Q1 FY26: revenue $29.0M, down 11%; diluted EPS −$2.22

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Stem reported for Q1 FY26, the quarter ended Mar 31, 2026, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$29.0M−11% from $32.5M in Q1 FY2510-Q income statement, on EDGAR
  2. Diluted EPS−$2.22Against −$3.00 in Q1 FY2510-Q income statement, on EDGAR
  3. Cash and cash equivalents$36.6M−38% from $58.6M in Q1 FY2510-Q balance sheet, on EDGAR
  4. Cash from operations−$8.3M−197% from $8.5M in Q1 FY2510-Q cash flow statement, on EDGAR

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Stem files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (7373) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. CSLM Acquisition CSLMF
  2. Healthcare Triangle HCTI public float $41M, Jun 30, 2025
  3. Veea VEEA public float $40M, Jun 30, 2025
  4. Future Vision II Acquisition FVN public float $61M, Dec 31, 2025
  5. Odysight.ai ODYS public float $35M, Jun 30, 2025